duoogle RBC Capital Markets has downgraded Verrica Pharmaceuticals ( NASDAQ: VRCA ) to sector perform from outperform. The investment firm pointed to several issues confronting the company, including a reshuffling of upper management, an ongoing strategic review, and continuing problems with the YCANTH launch..
